Page last updated: 2024-08-17

carbostyril and Chlamydia pneumoniae Infections

carbostyril has been researched along with Chlamydia pneumoniae Infections in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hammerschlag, MR; Reznik, T; Roblin, PM1
Hammerschlag, MR1
Knirsch, C; Luchsinger, JA; Pablos-Méndez, A; Rabinowitz, D; Shea, S1

Reviews

1 review(s) available for carbostyril and Chlamydia pneumoniae Infections

ArticleYear
Pneumonia due to Chlamydia pneumoniae in children: epidemiology, diagnosis, and treatment.
    Pediatric pulmonology, 2003, Volume: 36, Issue:5

    Topics: Adolescent; Anti-Bacterial Agents; Antibodies, Bacterial; Child; Child, Preschool; Chlamydophila Infections; Chlamydophila pneumoniae; DNA, Bacterial; Humans; Infant; Infant, Newborn; Macrolides; Pneumonia, Bacterial; Quinolones; Sensitivity and Specificity; Tetracyclines

2003

Other Studies

2 other study(ies) available for carbostyril and Chlamydia pneumoniae Infections

ArticleYear
In vitro activity of garenoxacin against recent clinical isolates of Chlamydia pneumoniae.
    International journal of antimicrobial agents, 2003, Volume: 21, Issue:6

    Topics: Adult; Anti-Infective Agents; Canada; Chlamydophila Infections; Chlamydophila pneumoniae; Community-Acquired Infections; Fluoroquinolones; Humans; Indoles; Japan; Microbial Sensitivity Tests; Pneumonia, Bacterial; Quinolones; United States

2003
Relation of antibiotic use to risk of myocardial infarction in the general population.
    The American journal of cardiology, 2002, Jan-01, Volume: 89, Issue:1

    Topics: Anti-Bacterial Agents; Cephalosporins; Chlamydophila Infections; Chlamydophila pneumoniae; Databases, Factual; Female; Humans; Insurance; Macrolides; Male; Medical Records; Middle Aged; Myocardial Infarction; Penicillins; Pneumonia, Bacterial; Proportional Hazards Models; Quinolones; Retrospective Studies; Risk Factors; Tetracyclines; Trimethoprim, Sulfamethoxazole Drug Combination; United States

2002